NCT07045896View on ClinicalTrials.gov

Fucoidan in the Treatment of Active Rheumatoid Arthritis

NANot yet recruitingINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

July 31, 2026

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

Fucoidan

Background Therapy: Continued pre-existing conventional RA treatment at stable doses Intervention: Oral fucoidan Dosage Form: Size-0 gelatin capsules containing 1000mg fucoidan powder Dosage: 2000mg (2 capsules) per dose, twice daily (BID) Duration: 12 weeks continuous treatment

DRUG

Corn starch

Background Therapy: Continued pre-existing conventional RA treatment at stable doses Intervention: Oral Corn starch as Placebo Dosage Form: Size-0 gelatin capsules containing 1000mg Placebo powder Dosage: 2000mg (2 capsules) per dose, twice daily (BID) Duration: 12 weeks continuous treatment

All Listed Sponsors
lead

Peking University People's Hospital

OTHER